Review

[Molecular Biology Reports] The dynamic communication between CSCs and tumor microenvironment particularly immune cells orchestrates their fate and plasticity as well as the patient outcome.

[European Journal Of Pharmaceutical Sciences] Nanotechnology presents a novel, powerful tool in the fight against cancer, particularly in targeting the elusive and treatment-resistant CSCs.

[Heliyon] The emergence of MSCs and their exosomes has opened up an expansive realm of potential and optimism for addressing the plight of acute lung injury/acute respiratory distress syndrome patients, as MSCs and their derived exosomes exhibited multifaceted capabilities, including anti-inflammatory properties, facilitation of tissue repair and regeneration, and apoptosis inhibition.

[Signal Transduction And Targeted Therapy] The authors discuss the developments for the therapeutic targeting of mTOR signaling with improved anticancer efficacy for the benefit of cancer patients in clinics.

[Nature Reviews Immunology] Scientists focus on the key obstacles pertaining to vaccine design and tumor environment that remain to be overcome in order to unleash the true potential of neoantigen vaccines in cancer therapy.

[HIV Medicine] The authors review the evidence on the incidence and impact of herpes zoster among people living with HIV and the potential impact of recombinant zoster vaccine for people aging with HIV.